Sirt3 deficiency induced down regulation of insulin degrading enzyme in comorbid Alzheimer’s disease with metabolic syndrome
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Sirt3 deficiency induced down regulation of insulin degrading enzyme in comorbid Alzheimer’s disease with metabolic syndrome ; volume:12 ; number:1 ; day:17 ; month:11 ; year:2022 ; pages:1-14 ; date:12.2022
Scientific reports ; 12, Heft 1 (17.11.2022), 1-14, 12.2022
- Creator
-
Tyagi, Alpna
Musa, Musa
Labeikovsky, Wladimir
Pugazhenthi, Subbiah
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-022-23652-5
- URN
-
urn:nbn:de:101:1-2023013021052935204265
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:37 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Tyagi, Alpna
- Musa, Musa
- Labeikovsky, Wladimir
- Pugazhenthi, Subbiah
- SpringerLink (Online service)
Other Objects (12)
Salidroside reduces neuropathology in Alzheimer’s disease models by targeting NRF2/SIRT3 pathway
Kai-Xin-San protects against mitochondrial dysfunction in Alzheimer’s disease through SIRT3/NLRP3 pathway
Monoamine alterations in Alzheimer’s disease and their implications in comorbid neuropsychiatric symptoms
Spatial memory deficiency early in 6xTg Alzheimer’s disease mouse model
Microglial CD2AP deficiency exerts protection in an Alzheimer’s disease model of amyloidosis
Alzheimer’s Disease
CX3CR1 deficiency aggravates amyloid driven neuronal pathology and cognitive decline in Alzheimer’s disease
White matter inflammation and cognitive function in a co-morbid metabolic syndrome and prodromal Alzheimer’s disease rat model
Functional markers for cerebral norepinephrine deficiency in Alzheimer's disease
Insulin-degrading enzyme (IDE) as a modulator of microglial phenotypes in the context of Alzheimer’s disease and brain aging
Microglial-associated responses to comorbid amyloid pathology and hyperhomocysteinemia in an aged knock-in mouse model of Alzheimer’s disease
Alzheimer
Salidroside reduces neuropathology in Alzheimer’s disease models by targeting NRF2/SIRT3 pathway
Kai-Xin-San protects against mitochondrial dysfunction in Alzheimer’s disease through SIRT3/NLRP3 pathway
Monoamine alterations in Alzheimer’s disease and their implications in comorbid neuropsychiatric symptoms
Spatial memory deficiency early in 6xTg Alzheimer’s disease mouse model
Microglial CD2AP deficiency exerts protection in an Alzheimer’s disease model of amyloidosis
Alzheimer’s Disease
CX3CR1 deficiency aggravates amyloid driven neuronal pathology and cognitive decline in Alzheimer’s disease
White matter inflammation and cognitive function in a co-morbid metabolic syndrome and prodromal Alzheimer’s disease rat model
Functional markers for cerebral norepinephrine deficiency in Alzheimer's disease
Insulin-degrading enzyme (IDE) as a modulator of microglial phenotypes in the context of Alzheimer’s disease and brain aging
Microglial-associated responses to comorbid amyloid pathology and hyperhomocysteinemia in an aged knock-in mouse model of Alzheimer’s disease
Alzheimer
Salidroside reduces neuropathology in Alzheimer’s disease models by targeting NRF2/SIRT3 pathway
Kai-Xin-San protects against mitochondrial dysfunction in Alzheimer’s disease through SIRT3/NLRP3 pathway
Monoamine alterations in Alzheimer’s disease and their implications in comorbid neuropsychiatric symptoms
Spatial memory deficiency early in 6xTg Alzheimer’s disease mouse model
Microglial CD2AP deficiency exerts protection in an Alzheimer’s disease model of amyloidosis
Alzheimer’s Disease
CX3CR1 deficiency aggravates amyloid driven neuronal pathology and cognitive decline in Alzheimer’s disease
White matter inflammation and cognitive function in a co-morbid metabolic syndrome and prodromal Alzheimer’s disease rat model
Functional markers for cerebral norepinephrine deficiency in Alzheimer's disease
Insulin-degrading enzyme (IDE) as a modulator of microglial phenotypes in the context of Alzheimer’s disease and brain aging
Microglial-associated responses to comorbid amyloid pathology and hyperhomocysteinemia in an aged knock-in mouse model of Alzheimer’s disease